Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Defines Distinct PGx, Cogenic and Diagnostic Units: Mar 1, 2006 (rev. 1)

NEW YORK, March 1, (GenomeWeb News) - Clinical Data announced today the division of its business into three units.

 

They are PGxHealth, Cogenics, and Vital Diagnostics.

 

The PGX Health division includes assets from newly acquired Genaissance to develop therapeutic diagnostics. The unit is developing CNS, cardiovascular, and oncology tests, the company said in a statement.

 

The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.

 

Vital Diagnostics, derived from the operations of Clinical Data, Vital, and Electa Labs, is geared toward IVD services for customers in 100 countries.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.